Apogee
Apogee Therapeutics reports the first data on the drug in long -term eczema
Adam Feuerstein is a main writer and biotechnology columnist, reporting on the crossroads of drug development, business, Wall Street and biotechnology. He is also co-host of the weekly biotech podcast The Readout Loud and author of the Biotech dashboard of the Adam newsletter. You can reach Adam on the signal to stataf.54. Apogee Therapeutics said […]
1 min read